Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Trials ; 25(1): 288, 2024 Apr 29.
Article in English | MEDLINE | ID: mdl-38685032

ABSTRACT

BACKGROUND: Acute kidney injury (AKI) is a significant postoperative complication associated with increased mortality and hospital costs. Hemodynamic strategies, such as goal-directed therapy, might reduce AKI risk. Predicting and proactively managing intraoperative hypotension may be helpful. This trial aims to investigate if a preemptive hemodynamic strategy guided by the hypotension prediction index (HPI) can decrease the incidence of moderate-to-severe AKI within 30 days following major elective abdominal surgery. METHODS: This is an open-label, controlled, multicenter, randomized clinical trial that involves daily patient follow-up until hospital discharge. Inclusion criteria are patients aged over 65 and/or categorized as ASA III or IV physical status, undergoing major elective abdominal surgery (general, urological, or gynecological procedures) via laparoscopic or open approach under general or combined anesthesia. INTERVENTION: In the intervention group, hemodynamic management will be based on the HPI and the advanced functional hemodynamic variables provided by the Hemosphere platform and the AcumenIQ® sensor (Edwards Lifesciences). The primary outcome is the incidence of moderate-to-severe AKI within 7 days post-surgery. Secondary outcomes include postoperative complications and 30-day mortality. DISCUSSION: This study explores the potential of HPI-guided hemodynamic management in reducing AKI after major elective abdominal surgery, with implications for postoperative outcomes and patient care. TRIAL REGISTRATION: ClinicalTrials.gov NCT05569265. Registered on October 6, 2022.


Subject(s)
Abdomen , Acute Kidney Injury , Hypotension , Multicenter Studies as Topic , Randomized Controlled Trials as Topic , Humans , Acute Kidney Injury/prevention & control , Acute Kidney Injury/etiology , Acute Kidney Injury/therapy , Acute Kidney Injury/diagnosis , Abdomen/surgery , Hypotension/prevention & control , Hypotension/etiology , Elective Surgical Procedures , Postoperative Complications/prevention & control , Postoperative Complications/etiology , Treatment Outcome , Female , Aged , Time Factors , Hemodynamics , Male , Early Goal-Directed Therapy , Risk Factors
2.
Acta Trop ; 249: 107074, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37956821

ABSTRACT

Hemotrophic mycoplasmas (hemoplasmas) are epierythrocytic bacteria that infect wild and domestic animals, and can cause anemia in some of them. They are considered emerging and zoonotic pathogens, causing serious health problems in wildlife. Candidatus Mycoplasma haemolamae is the only species of hemoplasma that infects domestic South American camelids (alpacas and llamas), with limited studies in wild camelids. Therefore, the objective of this study was to determine the prevalence of Candidatus M. haemolamae in vicunas (Vicugna vicugna) from the Pampa Galeras National Reserve, located in the Ayacucho region of Peru, using molecular diagnosis. For this, blood samples from 79 vicunas were collected, which were molecularly analyzed by partially amplifying the 16S ribosomal RNA gene of Mycoplasma sp. Fourteen vicunas (17.7 %) were positive for the molecular diagnosis of Mycoplasma sp. All PCR-positive products were sequenced and showed more than 99 % identity with Candidatus M. haemolamae. Statistical analysis showed that tick-infested vicunas had 6.10 odds of presenting Candidatus M. haemolamae compared with tick-free vicunas. Sex and age were not associated with Candidatus M. haemolamae infections. This is the first report of hemoplasmas in vicunas, a wild South American camelid, demonstrating that the pathogen can have both a domestic and a wild life cycle. Future studies are necessary to know the current situation of this pathogen in domestic and wild camelids from other locations in Peru.


Subject(s)
Camelids, New World , Mycoplasma , Animals , Camelids, New World/microbiology , Peru/epidemiology , Animals, Domestic , Mycoplasma/genetics , Animals, Wild , RNA, Ribosomal, 16S/genetics
3.
J Pers Med ; 10(3)2020 Sep 21.
Article in English | MEDLINE | ID: mdl-32967112

ABSTRACT

BACKGROUND: B-acute lymphoblastic leukemia (B-ALL) is a hematological neoplasm of the stem lymphoid cell of the B lineage, characterized by the presence of genetic alterations closely related to the course of the disease. The number of alterations identified in these patients grows as studies of the disease progress, but in clinical practice, the conventional techniques frequently used are only capable of detecting the most common alterations. However, techniques, such as next-generation sequencing (NGS), are being implemented to detect a wide spectrum of new alterations that also include point mutations. METHODS: In this study, we designed and validated a comprehensive custom NGS panel to detect the main genetic alterations present in the disease in a single step. For this purpose, 75 B-ALL diagnosis samples from patients previously characterized by standard-of-care diagnostic techniques were sequenced. RESULTS: The use of the custom NGS panel allowed the correct detection of the main genetic alterations present in B-ALL patients, including the presence of an aneuploid clone in 14 of the samples and some of the recurrent fusion genes in 35 of the samples. The panel was also able to successfully detect a number of secondary alterations, such as single nucleotide variants (SNVs) and copy number variations (CNVs) in 66 and 46 of the samples analyzed, respectively, allowing for further refinement of the stratification of patients. The custom NGS panel could also detect alterations with a high level of sensitivity and reproducibility when the findings obtained by NGS were compared with those obtained from other conventional techniques. CONCLUSIONS: The use of this custom NGS panel allows us to quickly and efficiently detect the main genetic alterations present in B-ALL patients in a single assay (SNVs and insertions/deletions (INDELs), recurrent fusion genes, CNVs, aneuploidies, and single nucleotide polymorphisms (SNPs) associated with pharmacogenetics). The application of this panel would thus allow us to speed up and simplify the molecular diagnosis of patients, helping patient stratification and management.

4.
Front Physiol ; 10: 1475, 2019.
Article in English | MEDLINE | ID: mdl-31849717

ABSTRACT

Chest compressions during cardiopulmonary resuscitation (CPR) generate cardiac output during cardiac arrest. Their quality performance is key to achieving the return of spontaneous circulation. Serious thoracic injuries (STIs) are common during CPR, and they can change the shape and mechanics of the thorax. Little is known about their hemodynamic effects, so a review of this emerging concept is necessary. The Campbell diagram (CD) is a theoretical framework that integrates the lung and chest wall pressure-volume curves, allowing us to assess the consequences of STIs on respiratory mechanics and hemodynamics. STIs produce a decrease in the compliance of the chest wall and lung. The representation of STIs on the CD shows a decrease in the intrathoracic negative pressure and a functional residual capacity decrease during the thoracic decompression, leading to a venous return impairment. The thorax with STIs is more vulnerable to the adverse hemodynamic effects of leaning, hyperventilation, and left ventricular outflow tract obstruction during CPR. A better understanding of the effects of STIs during CPR, and the study of avoidable injuries, can help to improve the effectiveness of chest compressions and the survival in cardiac arrest.

5.
Vet Parasitol ; 190(1-2): 294-6, 2012 Nov 23.
Article in English | MEDLINE | ID: mdl-22770680

ABSTRACT

Trombiculiasis is an infestation caused by larvae members of the family Trombiculidae, common called chigger mites. In this study is presented the first case of trombiculiasis caused by the infestation of chigger mite Eutrombicula in alpacas from Peru. Twenty-two alpacas of a total of 130 animals were infested by Eutrombicula sp. The chigger mite location was only in the face skin folds and around the eyes. In addition, all alpacas infested had alopecia and dermatitis in the infected zone.


Subject(s)
Camelids, New World/parasitology , Trombiculiasis/veterinary , Trombiculidae/classification , Alopecia/diagnosis , Alopecia/parasitology , Alopecia/veterinary , Animals , Dermatitis/diagnosis , Dermatitis/parasitology , Dermatitis/veterinary , Face/parasitology , Larva , Peru , Skin/parasitology , Trombiculiasis/diagnosis , Trombiculiasis/parasitology , Trombiculidae/anatomy & histology
8.
Br J Haematol ; 140(3): 324-6, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18067473

ABSTRACT

Lenalidomide combined with dexamethasone has significant clinical activity in the treatment of multiple myeloma (MM). In previous clinical trials lenalidomide-induced neutropenia was a frequent side-effect, often leading to treatment delays and dose reductions. We describe three MM patients treated with lenalidomide plus dexamethasone, which developed grade 3/4 neutropenia during the initial cycles, but without serious infection. Administration of granulocyte-colony stimulating factor (G-CSF) for 3 d prevented further neutropenia, treatment delays, dose reductions, or infectious complications during the following cycles. Consequently, G-CSF could be effective in preventing further neutropenia-related complications without compromising treatment efficacy in MM patients with lenalidomide-induced neutropenia.


Subject(s)
Antineoplastic Agents/adverse effects , Granulocyte Colony-Stimulating Factor/therapeutic use , Multiple Myeloma/drug therapy , Neutropenia/chemically induced , Thalidomide/analogs & derivatives , Aged , Antineoplastic Agents/therapeutic use , Clinical Trials as Topic , Dexamethasone/therapeutic use , Drug Administration Schedule , Drug Therapy, Combination , Female , Humans , Lenalidomide , Male , Middle Aged , Multiple Myeloma/complications , Neutropenia/complications , Neutropenia/drug therapy , Recombinant Proteins , Thalidomide/adverse effects , Thalidomide/therapeutic use , Treatment Outcome
9.
Ginecol Obstet Mex ; 72: 365-8, 2004 Jul.
Article in Spanish | MEDLINE | ID: mdl-15469177

ABSTRACT

The incidence of acute myocardial infarction related to pregnancy is of 10,000; it is less frequent during puerperium, since only 24 cases have been reported in literature. A young woman, without coronary risk factors, presented a myocardial infarction in the immediate puerperium.


Subject(s)
Myocardial Infarction , Puerperal Disorders , Adult , Female , Humans , Myocardial Infarction/diagnosis , Postpartum Period
SELECTION OF CITATIONS
SEARCH DETAIL
...